• World News
  • Investing
  • Tech News
  • Stock
  • Editor’s Pick
ResearchOfMarkets.com

While Trump has not yet turned to price controls to address America‘s absurdly high drug prices, Monday‘s executive order suggests that he soon may.

0 comment
0
FacebookTwitterPinterestEmail

previous post
A Closer Scrutiny of Affirmative Action (Reservation) Programs in India
next post
Tariffs Won’t Ever Be “Optimal”

You may also like

How Trump Can Lower Drug Prices Without Price...

May 14, 2025

USAID’s Legacy of Failure

May 14, 2025

Tariffs Won’t Ever Be “Optimal”

May 14, 2025

A Closer Scrutiny of Affirmative Action (Reservation) Programs...

May 14, 2025

The Tragedy of War

May 13, 2025

Wealth Generation and the Market Economy

May 13, 2025

The Salem Witch Tariffs: How Economic Witch Hunts...

May 13, 2025

The Classical Liberals Were Radical Opponents of War...

May 13, 2025

The Dehumanizing Nature of Tariffs

May 13, 2025

Explaining the Quirks in the GDP Report

May 12, 2025

    Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    Recent Posts

    • SMCI Stock Rebounds: Why Its SCTR Score is Screaming for Attention

      May 14, 2025

    • The S&P 500 Snapped Back Hard: Now What?

      May 14, 2025

    • Republicans’ One, Big, Beautiful Tax Bill Needs a Makeover

      May 14, 2025

    • Pharmaceutical Pricing Around the World

      May 14, 2025

    • How to Use Relative Strength in a Volatile Market

      May 14, 2025
    • Terms & Conditions
    • Privacy Policy
    • Contact us
    • About us

    Copyright © 2025 ResearchOfMarkets.com All Rights Reserved.

    ResearchOfMarkets.com
    • World News
    • Investing
    • Tech News
    • Stock
    • Editor’s Pick